J. Liang

发表

Administration of nimotuzumab combined with cisplatin plus 5-fluorouracil as induction therapy improves treatment response and tolerance in patients with locally advanced nasopharyngeal carcinoma receiving concurrent radiochemotherapy: a multicenter randomized controlled study

Rensheng Wang, Haixin Huang, X. Ning, 2019, BMC Cancer.

Efficacy and safety of PF299804 versus erlotinib (E): A global, randomized phase II trial in patients (pts) with advanced non-small cell lung cancer (NSCLC) after failure of chemotherapy (CT).

M. Krzakowski, S. Ramalingam, L. Denis, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy and safety of PF-00299804 (PF299) in patients (pt) with advanced NSCLC after failure of at least one prior chemotherapy regimen and prior treatment with erlotinib (E): A two-arm, phase II trial.

G. Giaccone, P. Jänne, F. Khuri, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dacomitinib versus erlotinib in patients with EGFR-mutated advanced nonsmall-cell lung cancer (NSCLC): pooled subset analyses from two randomized trials.

P. Jänne, K. O'Byrne, T. Mok, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Dacomitinib versus erlotinib in patients with EGFR-mutated advanced nonsmall-cell lung cancer (NSCLC): pooled subset analyses from two randomized trials.

P. Jänne, K. O'Byrne, T. Mok, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase II trial of tremelimumab (CP-675,206) in patients with advanced refractory or relapsed melanoma

A. Hauschild, J. Kirkwood, P. Hersey, 2008 .

Safety of tremelimumab (CP-675,206) in patients (pts) with advanced cancer

J. Gómez-Navarro, D. Healey, D. Pavlov, 2008 .

767O TREATMENT OF PATIENTS WITH ADVANCED REFRACTORY OR RELAPSED MELANOMA IN A PHASE II STUDY OF TREMELIMUMAB (CP-675,206), AN ANTI-CTLA4 MONOCLONAL ANTIBODY

A. Hauschild, D. Schadendorf, H. Pehamberger, 2008 .